Successful neurosurgery with transcranial MR-guided high-intensity focused ultrasound

June 22, 2009 Successful neurosurgery with transcranial MR-guided high-intensity focused ultrasound

Enlarge

A patient has been prepared for neurosurgery with transcranial MR-guided High-Intensity Focused Ultrasound (HIFU). Credit: MR Center, University Children's Hospital Zurich

The Magnetic Resonance Center of the University Children's Hospital Zurich has achieved a world first break through in MR-guided, non-invasive neurosurgery. Ten patients have been successfully treated by means of transcranial high-intensity focused ultrasound. This fully non-invasive procedure opens new horizons for neurosurgery and the treatment of different neurological brain disorders.

In the context of a clinical study at the MR Center of the University Children's Hospital Zurich transcranial MR-guided high-intensity focused ultrasound (HIFU) for surgery has been successfully applied for the first time world-wide. A research team under the direction of Professor Daniel Jeanmonod, neurosurgeon at the Department of Functional Neurosurgery of the Neurosurgical Clinic at the University Hospital Zurich and Professor Ernst Martin, director of the Magnetic Resonance Center at the University Children's Hospital Zurich succeeded in proving the safety and efficacy of this revolutionary surgical method which permits fully non-invasive brain interventions even on an out-patient basis.

For quite some years, HIFU has been used for the treatment of uterine fibroids and tumors of the prostate gland. However, its application to the brain through the intact skull for non-invasive neurosurgery was not possible until recently, because of insurmountable technical difficulties.

Non-invasive neurosurgery

In a Swiss National research project, the team of the University of Zurich successfully implemented and optimized a prototype system for transcranial Magnetic Resonance-guided High-Intensity Focused Ultrasound (HIFU) for neurosurgical interventions. The HIFU system ExAblate® 4000, developed by the cooperation partner InSightec, Tirat Carmel Israel, has been combined with a 3 Tesla high field GE MR-scanner. The two systems together provide a platform for image-guided, non-invasive interventions. Since September 2008 ten patients were treated at the Children's Hospital Zurich with this new neurosurgical procedure in the context of a clinical study. All interventions were completed successfully and without complications. This novel technology now opens up new horizons allowing to develop non-invasive intervention procedures for a variety of brain diseases including brain tumors.

The whole surgical procedure is planned and monitored in real time by magnetic resonance imaging (MRI). The HIFU beams produced by 1024 transducers are transferred through the intact skull of the patient into the brain and concentrated onto a focus of 3 to 4 millimeters in diameter. Thus, sharply defined targets deep inside the brain are coagulated by heating them up to a focal temperature of 60 degrees Celsius. The temperature increase during the sequential „sonications", each lasting 10 to 20 seconds, is continuously displayed and controlled on precise MR-temperature distribution maps. The whole surgical procedure lasts several hours and is performed without anaesthesia. Patients are awake and fully conscious during the intervention.

A project of the National Centre of Competence in Research (NCCR) Co-Me

In the context of the Swiss National Research Program NCCR Co-Me (computer aided and image guided medical interventions), the potential of non-invasive, transcranial MR-guided high-intensity focused ultrasound (tcMRgHIFU) is investigated in clinical studies at the University Children's Hospital Zurich. Scientists working in the Co-Me program pursue the goal of establishing and developing surgical interventions by means of tcMRgHIFU, in order to broaden the spectrum of completely non-invasive interventions for functional neurosurgery and for the treatment of brain tumors, stroke and various neurological brain disorders by targeted drug delivery.

The research project represents a co-operation between the University of Zurich and the ETH Zurich, through (A) the Center of the University Children's Hospital (Professor Ernst Martin), (B) the Department of Functional Neurosurgery of the Neurosurgical Clinic at the University Zurich (Professor Daniel Jeanmonod), (C) the Medical Image Analysis and Computer Vision Laboratory of the ETH Zurich (Professor Gabor Székely) and (D) the Institute of Neuroinformatics, ETH Zurich (PD Dr. Daniel Kiper), as well as the industrial partner InSightec Ltd.

Source: University of Zurich


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - 5 /5 (2 votes)


June 22, 2009 all stories

Comments: 0

5 /5 (2 votes)
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories

  • Children's Hospital Boston neurosurgeons to perform brain tumor removal during live Web cast
    created Oct 16, 2006 | popularity not rated yet | comments 0
  • Scientists pioneer new treatment for prostate cancer
    created Sep 15, 2008 | popularity not rated yet | comments 0
  • Major surgery no longer needed for the removal of uterine fibroids
    created Apr 11, 2008 | popularity not rated yet | comments 0
  • New surgery to reverse gigantism symptoms
    created Mar 13, 2007 | popularity not rated yet | comments 0
  • Brain surgery is getting easier on patients
    created Aug 20, 2008 | popularity not rated yet | comments 0



  • hide
  • Relevant PhysicsForums posts

  • The obesity epidemy
    created 8 hours ago
  • 23 Years in a Vegetative State....or not?
    created 13 hours ago
  • Has the H1N1 vaccine been scientifically proven to work?
    created Nov 24, 2009
  • nesfatin
    created Nov 22, 2009
  • Obsessive Compulsive Disorder
    created Nov 20, 2009
  • West's zone 2 starling resistor respiratory physiology
    created Nov 18, 2009
  • More from Physics Forums - Medical Sciences

Other News

Implant-based cancer vaccine is first to eliminate tumors in mice

Medicine & Health / Cancer

created 13 minutes ago | popularity not rated yet | comments 0

A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week in the journal Science Translational Medicine.


First 'genetic map' of Han Chinese may aid search for disease susceptibility genes

Medicine & Health / Genetics

created 15 minutes ago | popularity not rated yet | comments 0

The first genetic historical map of the Han Chinese, the largest ethnic population in the world, as they migrated from south to north over evolutionary time. was published online today by the American Journal of Human Ge ...


Medical students regularly stuck by needles, often fail to report injuries

Medicine & Health / Other

created 21 minutes ago | popularity not rated yet | comments 0

Medical students are commonly stuck by needles -- putting them at risk of contracting potentially dangerous blood-borne diseases -- and many of them fail to report the injuries to hospital authorities, according to a Johns ...


Feeding the clock

Feeding the clock: Cycles of feeding and fasting drive circadian gene expression in the liver

Medicine & Health / Research

created 3 hours ago | popularity 4 / 5 (1) | comments 0

When you eat may be just as vital to your health as what you eat, found researchers at the Salk Institute for Biological Studies. Their experiments in mice revealed that the daily waxing and waning of thousands ...


Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis

Medicine & Health / Cancer

created 1hour ago | popularity not rated yet | comments 0

Two signaling pathways essential to normal human development - the Wnt/Wingless (Wnt) and epidermal growth factor receptor (EGFR) pathways - interact in ways that can promote tumor cell invasion and metastasis, researchers ...